Showing results (381-390 of 403) with videos related to
Sort By:
Pageof 41
Balkan Journal of Medical Genetics : BJMG|September 21, 2013
Evidence for correlation of fragile sites and chromosomal breakpoints in carriers of constitutional balanced chromosomal rearrangementsT Liehr, N Kosayakova, J Schröder, et al.Frontiers in Cardiovascular Medicine|April 19, 2024
Extending heart preservation to 24 h with normothermic perfusionBrianna L Spencer, Spencer K Wilhelm, Christopher Stephan, et al.World Journal of Urology|July 7, 2025
Holmium laser enucleation of the prostate and strictures: long-term outcomes, stricture characteristics, and risk factorsMaximilian Glienke, A Sigle, R Himmelsbach, et al.Deutsche Medizinische Wochenschrift (1946)|February 25, 2010
[Uniliteral wheezes as the first clinical sign of a bronchial carcinoid]U M Becher, M Kaminski, C Grohe, et al.Nuklearmedizin. Nuclear Medicine|January 29, 2014
Survival after 131I-labeled lipiodol therapy for hepatocellular carcinoma. A single-center study based on a long-term follow-upH Ahmadzadehfar, E Habibi, S Ezziddin, et al.Clinical Neuroradiology|October 6, 2011
Mechanical thrombectomy compared to local-intraarterial thrombolysis in carotid T and middle cerebral artery occlusions: a single center experienceM Möhlenbruch, M Seifert, T Okulla, et al.HNO|March 14, 2013
[Dacryocystorhinostomy as part of the interdisciplinary treatment of lacrimal duct]S Herberhold, R Lindner, K Wilhelm, et al.Transplantation Proceedings|October 2, 2023
Twenty-Four Hour Normothermic Ex Vivo Heart Perfusion With Hemofiltration In an Adult Porcine ModelBrianna L Spencer, Spencer K Wilhelm, Kristopher A Urrea, et al.Science (New York, N.Y.)|October 29, 2000
Quantum superposition of macroscopic persistent-current statesC H van der Wal, A C ter Haar, F K Wilhelm, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development GroupP Schöffski, S Riggert, P Fumoleau, et al.Pageof 41